FDA releases new draft social media guidance

Share this article:
FDA released two guidance documents today for manufacturers and their representatives to communicate online about prescription drugs and medical devices.

The first draft guidance focused on recommendations for risk/benefit information on services with character space limitations, like Twitter and paid search on Google or Yahoo.

The second guidance discussed how to correct third-party information related to their own prescription drugs and medical devices, and stated that all misinformation should be addressed in a visible and defined portion of a forum on the internet or social media—regardless of whether it's positive or negative.

An in-depth analysis will follow tomorrow.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Imbruvica lassoes CLL indication

The FDA slapped a Breakthrough Therapy label on the CLL indication pursuit in February.

FDA asks social media "how'm I doin?"

The FDA's Center for Drug Evaluation and Research's Office of Communications wants a system that will help assess its messaging reach across the interwebs and its many forums.

Reckitt Benckiser wants out of pharma

The company plans to spin off its pharmaceutical unit.